Ontology highlight
ABSTRACT:
SUBMITTER: Bilezikian JP
PROVIDER: S-EPMC5818587 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature
Bilezikian J P JP Hattersley G G Fitzpatrick L A LA Harris A G AG Shevroja E E Banks K K Leder B Z BZ Zanchetta J R JR Hans D D
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20171122 2
In a phase 2 trial of 222 postmenopausal women with osteoporosis aged 55 to 85 years randomized to one of three different doses of abaloparatide-SC, subcutaneous teriparatide, or placebo for 24 weeks, abaloparatide-SC resulted in improvements in skeletal microarchitecture as measured by the trabecular bone score.<h4>Introduction</h4>Subcutaneous abaloparatide (abaloparatide-SC) increases total hip and lumbar spine bone mineral density and reduces vertebral and non-vertebral fractures. In this st ...[more]